Hyperplastic polyposis syndrome: phenotypic diversity and association to colorectal cancer

被引:5
|
作者
Navarro, Matilde [1 ]
Gonzalez, Sara [2 ]
Iglesias, Silvia [1 ]
Capella, Gabriel [2 ]
Rodriguez-Moranta, Francisco [3 ]
Blanco, Ignacio [1 ]
机构
[1] Inst Catala Oncol, Unidad Consejo Genet, Programa Canc Hereditario, Barcelona, Spain
[2] Inst Catala Oncol, Unidad Diagnost Mol, Programa Canc Hereditario, Barcelona, Spain
[3] Hosp Univ Bellvitge, Serv Gastroenterol, Barcelona, Spain
来源
MEDICINA CLINICA | 2013年 / 141卷 / 02期
关键词
Hyperplastic polyps; Hyperplastic polyposis; Serrated polyposis; Colorectal cancer; SERRATED POLYPS; RISK; COLONOSCOPY; PATHWAYS; ADENOMAS;
D O I
10.1016/j.medcli.2012.04.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objetive: Hyperplastic polyposis syndrome (HPS) is an uncommon disorder characterized by hyperplastic polyps (HP) occasionally associated with serrated adenomas (SA) or mixed polyps (MP) and defined by clinical criteria (OMS/Cleveland). HPS is heterogeneous regarding the number and size of polyps, and it is associated with colorectal cancer (CRC) and a family history. Its genetic basis is unknow. We describe individuals with HPS criteria from a series of families assessed in our Unit of Genetic Advice for colonic polyposis. Our objective is to identify the clinical characteristics of this syndrome. Patients and methods: Retrospective study of 197 families with colonic polyposis (1998-2011), identifying patients with HPS criteria. To know the number of polyps, we took into account polypectomies and/or the histologic study of surgical samples. Polyps were classified into adenomas, serrated lesiones (HP and SA) and MP. Genetic studies revealed: microsatellite instability (MSI), MUTYH gene variants (p.Tyr165Cys, p.Gly382Asp and p.Glu396GlyfsX43) and APC gene. Results: Eighteen individuals, with a median age of 51.1 years, had criteria of HPS (11 M/7 F). Number of HP varied between 14 and 100 coexisting with classical adenomas, SA and MP in 14 individuals (77.8%). Localization of polyps: ascending and descending colon in 13 individuals (72.2%) and only descending colon in 5 (27.8%). A CRC was detected in 10/18 (55.6%) patients, and 3 of them had a double CRC, a family history in 3 patients (16.7%) and a history of HPS in one. IMS was not detected in 8 CRC nor in 3 adenomas studied; we detected 2/13 heterozygous mutations in the MUTYH gene (p.Gly382Asp) and one variant with an unknown biological significance in the APC gene (p.Ser926Pro). Conclusions: The phenotypic variability of HPS difficults its identification, hence it is important to adhere to the clinical criteria established for its classification as well as to establish screening guidelines for CRC on the basis of its high incidence. (C) 2012 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:62 / 66
页数:5
相关论文
共 50 条
  • [31] Serrated polyposis syndrome and colorectal cancer
    Hugh Thomas
    Nature Reviews Gastroenterology & Hepatology, 2016, 13 (1) : 2 - 2
  • [32] Hyperplastic polyposis and the risk of colorectal cancer [Hyperplastische polyposis und das risiko eines kolorektalkarzinoms]
    Hyman N.H.
    Anderson P.
    Blasyk H.H.
    coloproctology, 2005, 27 (5) : 275 - 279
  • [33] DEFINING PHENOTYPES AND CANCER RISK IN HYPERPLASTIC POLYPOSIS SYNDROME.
    Kalady, M.
    Jarrar, A.
    LaGuardia, L.
    O'Malley, M.
    Leach, B.
    Eng, C.
    Church, J.
    DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 550 - 550
  • [34] Hyperplastic-adenomatous polyposis syndrome
    Place, RJ
    Simmang, CL
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1999, 188 (05) : 503 - 507
  • [35] Phenotypic characteristics and risk of cancer development in hyperplastic polyposis:: Case series and literature review
    Ferrández, A
    Samowitz, W
    DiSario, JA
    Burt, RW
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : 2012 - 2018
  • [36] High prevalence of hyperplastic polyposis syndrome (serrated polyposis) in the NHS bowel cancer screening programme
    Biswas, Sujata
    Ellis, Antony J.
    Guy, Richard
    Savage, Helen
    Madronal, Karen
    East, James E.
    GUT, 2013, 62 (03) : 475 - 475
  • [37] EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis
    Kokko, Antti
    Laiho, Paeivi
    Lehtonen, Rainer
    Korja, Sanna
    Carvajal-Carmona, Luis G.
    Jaervinen, Heikki
    Mecklin, Jukka-Pekka
    Eng, Charis
    Schleutker, Johanna
    tomlinson, Ian P. M.
    Vahteristo, Pia
    Aaltonen, Lauri A.
    BMC CANCER, 2006, 6 (1)
  • [38] EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis
    Antti Kokko
    Päivi Laiho
    Rainer Lehtonen
    Sanna Korja
    Luis G Carvajal-Carmona
    Heikki Järvinen
    Jukka-Pekka Mecklin
    Charis Eng
    Johanna Schleutker
    Ian PM Tomlinson
    Pia Vahteristo
    Lauri A Aaltonen
    BMC Cancer, 6
  • [39] An association between hyperplastic polyposis syndrome and cigarette smoking, a modifiable risk factor
    Walker, G.
    Whitehall, V. L.
    Knight, N.
    Buttenshaw, R. L.
    Hewett, D. G.
    Worthley, D.
    Leggett, B. A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A209 - A209
  • [40] Colorectal carcinomas arising in the hyperplastic polyposis syndrome progress through the chromosomal instability pathway
    Hawkins, NJ
    Gorman, P
    Tomlinson, IPM
    Bullpitt, P
    Ward, RL
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (02): : 385 - 392